Zhejiang Tailin Bioengineering Co

Zhejiang Tailin Bioengineering Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Zhejiang Tailin Bioengineering Co (300813.SZ) as of Oct 29, 2026 is 62.00 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 46.88 % — a change of 32.24% (higher).

FCF Conversion

62.00 %

YoY

32.24%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Zhejiang Tailin Bioengineering Co is 2025 62.00 % . FCF Conversion Rate (FCF/EBITDA) of Zhejiang Tailin Bioengineering Co was 2024 46.88 % . It decreases by 32.24% higher compared to the previous year.

The Zhejiang Tailin Bioengineering Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-10.31 CNY
Jan 1, 2019
19.38 CNY
Jan 1, 2020
205.05 CNY
Jan 1, 2021
15.82 CNY
Jan 1, 2022
75.60 CNY
Jan 1, 2023
-886.22 CNY
Jan 1, 2024
46.88 CNY
Jan 1, 2025
62.00 CNY
The Zhejiang Tailin Bioengineering Co FCF Conversion history
YEARFCF ConversionYoY
62.00 %+32.24%
46.88 %-105.29%
-886.22 %-1,272.26%
75.60 %+377.84%
15.82 %-92.28%
205.05 %+958.10%
19.38 %-288.05%
-10.31 %+32.51%
-7.78 %-113.03%
59.69 %-58.89%
145.20 %-10.61%
162.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Tailin Bioengineering Co Stock analysis

What does Zhejiang Tailin Bioengineering Co do? Zhejiang Tailin Bioengineering Co., Ltd. generates revenue through the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products and organic substance analysis instruments. The company's main products consist of consumables, instruments, and equipment used in sterile drug production and quality control, targeting pharmaceutical manufacturers and laboratories. These products serve applications in medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection sectors. The firm distributes its products domestically and internationally, with a focus on the Chinese market and overseas markets. The company's revenue streams are derived from the sale of microbial detection and control technology system products, organic substance analysis instruments, and related consumables. Pharmaceutical manufacturers and laboratory facilities are the primary customers purchasing these products for quality assurance and production processes. The application segments include medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection, which are served through both domestic and international distribution channels. Zhejiang Tailin Bioengineering's business model centers on selling specialized pharmaceutical equipment to industries requiring sterile drug production and quality control. The firm's products are utilized across multiple sectors such as medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. Sales occur within the domestic market and overseas markets, with a strong emphasis on the Chinese market and international expansion. Zhejiang Tailin Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Tailin Bioengineering Co stock

FCF Conversion Rate (FCF/EBITDA) of Zhejiang Tailin Bioengineering Co is 62.00 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Zhejiang Tailin Bioengineering Co changed from 46.88 % to 62.00 %, representing a 32.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Zhejiang Tailin Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Zhejiang Tailin Bioengineering Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Zhejiang Tailin Bioengineering Co

All Key Metrics — Zhejiang Tailin Bioengineering Co